Neurocrine Acquires Soleno in US Business News
As the biotech landscape continues to evolve, one major deal is making waves in the United States market: Neurocrine Biosciences, a leading developer of innovative treatments for neurological and endocrine disorders, is set to acquire Soleno Therapeutics, a company specializing in the development of rare disease treatments, in a whopping $2.9 billion transaction. This strategic […]
Neurocrine Acquires Soleno in US Business News Read More »







